Harbin Gloria Pharmaceuticals Co Ltd Class A 002437
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 2.14
- Day Range
- CNY 2.13–2.18
- 52-Week Range
- CNY 1.67–3.15
- Bid/Ask
- CNY 2.16 / CNY 2.17
- Market Cap
- CNY 4.93 Bil
- Volume/Avg
- 54.1 Mil / 49.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 23.61
- Price/Sales
- 1.89
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,507
- Website
- http://www.gloria.cc
Comparables
Valuation
|
Metric
|
002437
|
603439
|
002872
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.61 | 24.81 | — |
Price/Book Value | 2.72 | 4.17 | 0.66 |
Price/Sales | 1.89 | 3.73 | 2.40 |
Price/Cash Flow | 13.68 | 22.41 | 67.73 |
Price/Earnings
002437
603439
002872
Financial Strength
|
Metric
|
002437
|
603439
|
002872
|
|---|---|---|---|
Quick Ratio | 0.76 | 1.65 | 1.38 |
Current Ratio | 0.94 | 1.96 | 1.70 |
Interest Coverage | 6.85 | 44.37 | −6.48 |
Quick Ratio
002437
603439
002872
Profitability
|
Metric
|
002437
|
603439
|
002872
|
|---|---|---|---|
Return on Assets (Normalized) | 2.07% | 12.93% | −4.38% |
Return on Equity (Normalized) | 4.20% | 21.60% | −5.95% |
Return on Invested Capital (Normalized) | 3.14% | 16.14% | −4.90% |
Return on Assets
002437
603439
002872
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Nxvnqgsc | Mzsv | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Pskmvrgz | Mhnvh | $69.1 Bil | |
HLN
| Haleon PLC ADR | Gbjcxpq | Vnzx | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Jxkywzcx | Nzxx | $15.6 Bil | |
VTRS
| Viatris Inc | Cjbpbfhf | Tcrp | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xpknpzq | Hbfh | $12.4 Bil | |
CTLT
| Catalent Inc | Lvvlbrp | Ldxnh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Srthxvpkk | Tpz | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Rvrkswn | Lbhd | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Llpztvp | Nwxdhn | $3.5 Bil |